Navigation Links
Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver

CHICAGO, Dec. 30, 2011 /PRNewswire/ -- Four free stock picks are being made available today on The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.


The four highlighted picks are: Chemtura Corporation (NYSE: CHMT), Cardinal Health, Inc. (NYSE: CAH), HiTech Pharmacal Co, Inc. (Nasdaq: HITK) and Gardner Denver, Inc. (NYSE: GDI).

Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free.

From 1988 through the present – a period that included serious corrections and recessions – the Zacks #1 Rank Stocks have nearly tripled the market with a fully documented average gain of +28% per year.

Here is a summary of today's selected stocks that are now highly rated by Zacks:          

Aggressive Growth – Chemtura Corporation (NYSE: CHMT)

Chemtura Corporation analysts move earnings estimates higher.

Zacks Guide to Aggressive Growth Investing (free!) -

Growth & Income – Cardinal Health, Inc. (NYSE: CAH)

Cardinal Health, Inc. carried its strong momentum into the first quarter of its fiscal 2012 and delivered its 9th consecutive positive earnings surprise. Analysts raised their estimates after the strong quarter for both 2012 and 2013, sending the stock to a Zacks #2 Rank (Buy).

Zacks Guide to Growth & Income Investing (free!) -

Momentum – HiTech Pharmacal Co, Inc. (Nasdaq: HITK)

HiTech Pharmacal Co, Inc. just hit a new all-time high after reporting strong Q3 results that included an impressive 35% earnings surprise. With estimates on the rise and a high industry rank, this Zacks #1 rank stock is a solid pick for momentum.

Zacks Guide to Momentum Investing (free!):

Value – Gardner Denver, Inc. (NYSE: GDI)

Gardner Denver, Inc. is still on track for double digit earnings growth in 2012 after posting several record quarters in 2011. This Zacks #1 Rank (strong buy) has attractive valuations with a forward P/E of 13.8.

Zacks Guide to Value Investing (free!) -

How to Regularly Access Top Zacks Rank Picks for Free -

Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. from M.I.T. found that "earnings estimate revisions are the most powerful force impacting stock prices."  Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.

Today, Zacks is promoting its stock recommendations by offering four daily picks free to those who register here:

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms.  It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they're applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.

More Free Stock Picks

Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription here:

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339

Visit for information about the performance numbers displayed in this press release.

SOURCE Zacks Investment Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
2. The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories and Abbott Laboratories
3. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
4. Zacks Investment Research Initiates Coverage on Viral Genetics
5. Zacks Rates CardioGenics Outperform With Six-Month Target of $1.22
6. Medical Alarm Concepts Releases Initial Cut of New Television Commercial Scheduled for January Airing - Provides Investor Update
7. SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit
8. Talyst Releases AutoPharm Mobile
9. UHC Releases Reprocessing Guide for Value Analysis Program
10. TRACE Releases Report on Bribe Demands in the United States
11. Bupa International Releases Health Guides to Hong Kong and Singapore
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
Breaking Medicine News(10 mins):